glp-1 prescriptions growth slowing 2024 Receptor Agonist Market Size GLP-1s like Ozempic are among

What specific benefits do GLP-1 receptor agonists offer beyond weight loss and glucose regulation, and how might these benefits influence their role in comprehensive metabolic disease management

Ideal Candidates You're likely a good candidate if you have BMI of 30+ (obesity) or 27+ with weight-related health conditions, have tried diet and exercise without sustained success, are ready to commit to healthier eating, want medically supervised, FDA-approved treatment, and can invest 6-12 months for optimal results

PMID: 1587302

We review your health history, your goals, and what you have already tried

However, a plausible mechanism does not automatically translate into meaningful clinical outcomes